Chris D. Geddes

Chris D. Geddes, PhD, FRSC, is a tenured Professor with the University of Maryland Baltimore County and the head of The Institute of Fluorescence, founded by Dr. Geddes in early 2001. The Institute's mission is to develop and deploy novel fluorescence techniques and tools to advance biosensing, bioimaging and to protect and safeguard human health. With an array of internationally known scientists as members, the Institute of Fluorescence boasts hundreds of man years of fluorescence experience. Dr. Geddes has extensive experience in fluorescence spectroscopy, particularly in fluorescence sensing and metal-fluorophore interactions, publishing over 250 peer-reviewed papers (h-index: 40), and 30 books. Dr Geddes is internationally known in fluorescence and plasmonics and his laboratory is widely attributed to the development of the Metal-Enhanced Fluorescence (MEF) and related plasmon-fluorescence technologies, securing in excess of $25 million in recent years to persue his research aspirations. He is the editor-in-chief of the Journal of Fluorescence and founding editor-in-chief of the Who’s Who in Fluorescence, Annual Reviews in Fluorescence and the Annual Reviews in Plasmonics volumes. In addition, due to the labs’ pioneering efforts in the fields of metallic nanoparticle-fluorophore interactions, Dr Geddes launched a Springer Journal "Plasmonics" in 2005, which is a leading journal in the field today. Dr Geddes has been a permanent member of the NIH’s EBIT R01 study section (2007-2012) and chaired the NIH’s Analytical and BioAnalytical SBIR study section from ~ 2004-2009. He is a fellow of both the Royal Society of Chemistry (FRSC) and the Institute of Physics. Dr Geddes holds > 100 patents in the fields of fluorescence and plasmonics. Dr Geddes's research group has developed a platform technology for the ultra fast and ultra sensitive detection of clinical analytes. The new technology combines the use of Metal-Enhanced Fluorescence (MEF) to amplify fluorescence signatures up to a million fold, with the use of low power microwaves. The resultant technology, Microwave-Accelerated Metal-Enhanced Fluorescence (MAMEF), when applied to antigen, antibody or protein detection, can be applied to STD identification without the need for time consuming laboratory processing and amplification, such as by real-time PCR. Dr Geddes utilizes his MAMEF technology with the Hopkins POC STD center.

Associated articles

JTEHM, Articles, Published Articles
National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network: Advancing Precision Medicine
This Article is Featured in the Special Issue NIH-IEEE POCT 2015 To advance the development of point-of-care technology (POCT), the National Institute of Biomedical Imaging and Bioengineering established the POCT Research Network (POCTRN), comprised of Centers that emphasize multidisciplinary partnerships and... Read more